Graphene nanoplatelets (GNPs) |
In vitro
|
Human bronchial epithelial cell line (BEAS-2B) |
Dose-dependently reduced cell viability, which was accompanied by an increase in the portion of cells in the subG1 and S phases, downregulated the generation of ROS, suppressed ATP production, damaged mitochondria, and elevated levels of autophagy-related proteins |
[181] |
|
In vivo
|
Mice |
Subchronic inflammatory response |
|
Graphene quantum dots (GQDs) |
In vitro
|
Cancer cell lines (KB, MDA-MB231, A549) Normal cell line (MDCK) |
No acute toxicity or morphological changes |
[182] |
Graphene quantum dots (GQDs) |
In vivo
|
Mice |
GQDs mainly accumulated in liver, spleen, lung, kidney, and tumor sites after intravenous injection. |
|
|
|
|
No toxicity to the treated animals or organ damage/lesions to treated mice after 21 days of administration at 5 mg/kg or 10 mg/kg dosages |
|
|
In vitro
|
HeLa (A549) cells |
Low cytotoxicity |
[212] |
|
In vivo
|
Mice |
No material accumulation in main organs and fast clearance of GQDs through kidney |
|
GO and rGO |
In vitro
|
HEK 293T cells |
Small and large sizes of G and GO significantly reduced the cell viability and increased DNA damage, accompanying with activated reactive oxygen species (ROS) generation and induced various expressions of associated critical genetic markers |
[183] |
|
In vivo
|
Zebrafish |
G showed stronger ability to decrease the survival rate and induce the acute toxicity, while GO showed obvious toxicity in terms of DNA damages, ROS generation, and abnormal gene expressions |
|
|
In vitro
|
Luminous Tox2 & RecA bacterial strains |
G and GO caused strong acute toxicity on Tox2 bacteria; G was more toxic than GO and showed size dependent effect with toxicity increasing with increase in size. GO induced mild genetic toxicity on RecA bacteria |
|
|
In vitro
|
Murine macrophage RAW 264.7 cells |
ROS-mediated toxic effects with pristine graphene |
[184] |
|
In vitro
|
E. coli; S. aureus
|
Bacteria cell membrane damage: GO at a concentration of 85 μg/ml could suppress the growth of E. coli after 2 h incubation at 37 °C |
[185] |
|
In vivo
|
Mice |
Chronic toxicity with high dose (0.4 mg) in lung, liver, spleen, kidney |
[189] |
|
In vitro
|
E. coli, Pseudomonas aeruginosa
|
No noticeable antimicrobial effect with GO alone |
[187] |
|
In vivo
|
Mice |
Accumulates in reticuloendothelial system (RES) organs, such as liver and spleen at early time points after IV injection |
[213] |
|
In vitro
|
Human platelets |
Evokes aggregatory response, which may play a role in hemostasis and thrombus formation |
[180] |
|
In vivo
|
Mice |
Thrombogenic |
|
|
In vitro
|
HeLa cells |
Dose-dependent toxicity |
[184] |
|
In vivo
|
Zebrafish |
Polyacrylic acid (PAA) was used to functionalize GO to reduce its toxicity to cells |
|
|
In vitro
|
A549 human epithelial cells |
GO does not enter A549 cell and has no obvious cytotoxicity, but can cause a dose-dependent oxidative stress in cell and induce a slight loss of cell viability at high concentration |
[214] |
|
In vivo
|
Mice |
Induce the mitochondrial generation of ROS, activate inflammatory and apoptotic pathways, and result in severe and persistent lung injury |
[184] |
|
In vitro
|
U87 and U118 glioma cell lines |
Both types of platelets reduced cell viability and proliferation with increasing doses, but rGO was more toxic than GO with rGO increasing the level of apoptotic markers in treated tumors |
[215] |
|
In vivo
|
Mice |
Short-term repeated GO exposure can cause obvious intraocular inflammation, an incrassated corneal stromal layer, cell apoptosis in the cornea, iris neovascularization and significant cytotoxicity of rat corneal epithelial cells (rCECs), while RGO causes no significant ocular toxicity in mice |
[190] |
Laponite® XLG, nanohybrids |
In vitro
|
Cancer cells (KB human epithelial carcinoma cells, MCF-breast cancer cells, CAL-72 osteosarcoma cell lines) |
Cytotoxicity towards cancer cells |
[216] |
|
In vivo
|
Mice |
Absence of organ toxicity 24 h and half a month post IV injection |
|
|
In vitro
|
Human mesenchymal stem cells (hMSCs) |
Non-toxic at concentrations less than 1 mg/ml |
[192] |
|
In vivo
|
Rats |
Implantation of Laponite bioceramics does not show acute systemic toxicity or irritation to normal skin of rats |
[193] |
MMT |
In vitro
|
INT-407 (intestinal) cells |
MMT could cause cytotoxic effects in a concentration- and time-dependent manner and at high concentration after long-time exposure |
[195] |
|
In vivo
|
Mice |
MMT absorbed within 2 h but did not accumulate in any specific organ or showed any remarkable toxicity |
|
|
In vitro
|
HUVE, N1E-115 and ROC-1 cell lines |
Decrease cell viability in HUVECs exposed for 24 h to 0.1 mg/ml but limited results in neuronal cell lines N1E-115 and ROC-1 |
[217] |
|
In vitro
|
CHO cells |
Reduction in cell viability after being exposed to 1 mg/ml for up to 24 h |
|
MMT nanocomposite (MMN) |
In vivo
|
Broiler chicks |
Addition of 3 g MMN/kg AF-contaminated diet diminished the adverse effects of AF on most relative organ weights, hematological values, serum and liver biochemical values and enzymatic activities associated with aflatoxicosis in broiler chicks |
[218] |
BP nanosheets |
In vitro
|
Human bronchial epithelial cells |
BP nanosheets decrease viability of these cells in a time- and dose-dependent manner via interference with mitochondrial membrane potential, leading to an increase in intracellular ROS, activation of caspase-3, and apoptosis |
[219] |
|
In vivo
|
Mice |
Single injection of BP nanosheets does not cause toxicity in a short period of time, whereas multiple injections of BP nanosheets exert adverse effects on liver and renal function |
|
BP quantum dots (BPQDs) |
In vitro
|
HeLa cells |
At high concentration (200 μg/ml) exhibit significant apoptotic effects |
[211] |
|
In vivo
|
Mice |
BPQD can transiently induce oxidative stress, including lipid peroxidation, reduction of catalase activity, DNA breaks, and bone marrow nucleated cells (BMNC) damage, but recovered gradually to healthy levels and no pathological damage to organs is apparent |
|
Black phosphorus (BP)-quantum dots (QDs) |
In vitro
|
Kidney organoid |
Moderate toxicity |
[209] |
|
In vitro
|
Huma renal tubular epithelial cells |
Nephrotoxicity |
|
|
In vivo
|
Mice |
Nephrotoxicity - found to cause insulin insensitivity and endoplasmic reticulum strees in the kidney |
|
MoS2, WS2, and WSe2
|
In vitro
|
Lung epithelial carcinoma cells |
WS2 elicit slightly more toxic responses whereas MoS2 and WS2 are safe and less hazardous |
[199] |
MoS2 nanosheets |
In vitro
|
NIH-3T3 murine embryo fibroblast cells and the human adipose derived mesenchymal stem cells |
Mild toxicity |
[220] |
|
|
Human embryonic lung fibroblast (HELF) cells |
Bovine serum albumin (BSA) coating diminished the toxic effect, and both coated and uncoated NPs promoted the proliferation of HELF cells, which, as a pathological process, can lead to idiopathic pulmonary fibrosis |
|
|
In vitro
|
HepG2 cells |
Cell membrane disruption: ROS level and the mitochondrial membrane potential were altered in the treated cells, suggesting oxidative stress and apoptosis induction; inhibition of ABC transporter |
|
|
In vitro
|
BEAS-2B immortalized human bronchial epithelial cells; THP-1 human monocytic cells |
Cell viability unaltered with proinflammatory effect for aggregates and low effect for nanoforms |
|
|
In vivo
|
Mice |
Proinflammatory effect for aggregates and low effect for nanoforms |
|
MoS2 nanofilm and microparticles |
In vitro
|
PANC1 human pancreatic cancer cells; 293 human embryonic kidney cells; human pancreatic duct epithelial (HPDE) cells; human mammary epithelial (HMLE) cells; SUM159 mesenchymal triple-negative breast cancer cells; MDAMB-231 invasive ductal breast carcinoma cells |
Cell viability unaltered up to 0.016 mg/ml, slight decrease in viability for higher concentrations |
|
|
In vivo
|
Guinea pigs |
No skin allergy symptoms |
|
Molybdenum trioxide (MoO3) nanoparticles |
In vitro
|
Human MCF-7 (breast cancer) and HepG2 (hepatoma) |
Showed a dose-dependent decrease in viability at concentrations (25–0.625 μg/ml) |
|
|
|
C18–4 spermatogonial stem cell line |
Cell membrane integrity disruption |
|
|
|
BRL 3A cells (immortalized rat liver cells) |
Mildly toxic effect at 250 μg/ml but significant LDH leakage present at the concentration of ≥100 μg/ml. |
|
MoO2 and MoO3 nanocolloids |
In vitro
|
NIH/3T3 cell line |
Decreased viability in a concentration dependent manner associated with a change in the redox status of the cell, resulting in oxidative stress induction |
|
MoO3 nanoplates |
In vitro
|
Human breast cancer cells (MCF-7 and the invasive type MCF-7 with the CD44high/CD24low phenotype) and human keratinocyte (HaCaT) |
HaCaT cells did not show decreased viability, but both MCF-7 lines were susceptible and likely to involve the loss of the mitochondrial membrane potential and an induction of oxidative stress |
|
hBN nanosheets |
In vitro
|
E. coli DH5α |
Degradation of bacterial cell membranes (inner and outer layers) |
[201] |
hBN nanoparticles |
In vivo
|
Rats |
Damage in the liver, kidney, heart, spleen, and pancreas at 1600 and 3200 μg/kg doses |
[205] |
hBN nanosheets and nanoparticles |
In vitro
|
Osteoblast-like cells (SaOS2) |
Decrease in cell viability in presence of both nanosheets and nanoparticles with the smallest size likely attributed to internalization and activation of ROS |
[205] |
hBN flakes |
In vitro
|
Mouse hippocampal cell line (mHippo E14) |
No cytotoxic effects at hBN concentration lower than 22 μg/ml and favored the cell survival after exposure to doxorubicin |
|
Ti3C2 and Nb2C Mxene quantum dots |
In vitro
|
Human umbilical vein endothelia cells (HUVECs) |
Ti3C2 QDs could induce cytotoxicity to HUVECs at 100 μg/ml |
[221] |
MXene flake/Cu nanocomposite |
In vitro
|
3T3 mouse fibroblasts and HEK293 cells |
No toxic effects |
[222] |
Ti3C2Tx MXene film |
In vitro
|
Mouse pre-osteoblast cell line MC3T3E1 |
No cytotoxicity |
[207] |
|
In vivo
|
Rat calvaria |
No toxic or inflammatory effects; improves osteogenesis |
|
|
In vivo
|
Mice |
No adverse effects or pathological toxicity (20 mg/kg) |
|
MXene, Nb2C-PVP nanosheets |
|
|
|
[222, 223] |
MXene nanosheets |
In vivo
|
Avian embryos |
Adverse effect on the early stage of embryogenesis as ~46% of MXene-exposed embryos died during 1–5 days after exposure and may inhibit angiogenesis of the chorioallantoic membrane of the embryo after 5 days of incubation; seven genes that are key regulators of cell proliferation, survival, cell death and angiogenesis were deregulated in brain, heart, and liver tissues |
[224] |
|
In vivo
|
Zebra fish embryos |
LC50 of Ti3C2Tx was greater than 100 μg/ml, it can be classified as within the “practically nontoxic” group according to the Acute Toxicity Rating Scale by the Fish and Wildlife Service (FWS) |
[225] |